Showing 401 - 420 results of 497 for search '"Фармакоэкономика"', query time: 0.05s Refine Results
  1. 401
    Analysis of methotrexate use practice in patients with rheumatoid and psoriatic arthritis

    Analysis of methotrexate use practice in patients with rheumatoid and psoriatic arthritis by S. A. Doktorova, Yu. Yu. Grabovetskaya, A. V. Zuev, J. N. Aksenova-Sorokhtei, V. V. Rafalskiy

    Published 2025-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 402
    Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis

    Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis by А. V. Kukurika

    Published 2022-10-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 403
    Approaches to assessing the demand for medical personnel in the Russian Federation

    Approaches to assessing the demand for medical personnel in the Russian Federation by S. N. Tishkina, T. G. Alkhasov, D. V. Lukyantseva, T. P. Bezdenezhnykh

    Published 2019-10-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 404
    Comparative estimation of the effectiveness of the Khorana, Vienna CATS, and TiC-Onco scores and the vWF/ADAMTS13 ratio in identifying a high risk of thrombotic complications in patients with malignant neoplasms

    Comparative estimation of the effectiveness of the Khorana, Vienna CATS, and TiC-Onco scores and the vWF/ADAMTS13 ratio in identifying a high risk of thrombotic complications in pa... by A. V. Vorobеv, A. G. Solopova, V. O. Bitsadze, M. M. Baeva, M. E. Sosnyagova, V. N. Galkin, D. O. Utkin, A. D. Makatsariya

    Published 2025-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 405
    DISCUSSION

    DISCUSSION by Anna Yarvits

    Published 2017-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 406
    SYSTEMATIC LITERATURE REVIEW ON CLINICAL EFFICACY AND SAFETY OF ALOGLIPTIN IN COMPARISON WITH VILDAGLIPTIN, LINAGLIPTIN, SAXAGLIPTIN AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS

    SYSTEMATIC LITERATURE REVIEW ON CLINICAL EFFICACY AND SAFETY OF ALOGLIPTIN IN COMPARISON WITH VILDAGLIPTIN, LINAGLIPTIN, SAXAGLIPTIN AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 D... by Georgii Rubenovich Khachatryan, Vladislav Sergeevich Dombrovskii

    Published 2015-09-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 407
    Legal particularities of AI technology usage in real-world data formation

    Legal particularities of AI technology usage in real-world data formation by V. S. Malichenko, A. O. Gadzhieva, N. I. Platonova, A. Yu. Solovieva-Oposhnyanskaya

    Published 2024-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 408
    PARAMETERS OF HEALTH CARE SYSTEMS

    PARAMETERS OF HEALTH CARE SYSTEMS by V. V. Omelyanovskiy, I. V. Maksimova, A. P. Tatarinov

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 409
    Compounding pharmacy regulations: experience of the North American pharmaceutical market

    Compounding pharmacy regulations: experience of the North American pharmaceutical market by D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich

    Published 2023-04-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 410
    FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS

    FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS by A. S. Kolbin, O. K. Khmelnitskiy, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, E. P. Kolpak, M. V. Bure

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 411
    Medical care of ambulatory patients and its assessment: a review of international experience

    Medical care of ambulatory patients and its assessment: a review of international experience by D. V. Lukyantseva, O. A. Sukhorukikh, V. V. Omelyanovsky

    Published 2018-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 412
    WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM

    WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM by A. I. Borodin

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 413
    Presepsin as a sepsis biomarker

    Presepsin as a sepsis biomarker by K. A. Trunova

    Published 2018-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 414
    Decision modelling for the evaluation of diabetes outcomes

    Decision modelling for the evaluation of diabetes outcomes by A. A. Mosikian, W. Zhao, T. L. Galankin, A. S. Kolbin

    Published 2017-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 415
    THE COST OF NUTRITION ALTERNATIVES FOR PREMATURE INFANTS IN RUSSIA

    THE COST OF NUTRITION ALTERNATIVES FOR PREMATURE INFANTS IN RUSSIA by K. V. Gerasimova, M. V. Avxentyeva, I. A. Belyaeva

    Published 2016-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 416
    Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome)

    Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) by I. Yu. Torshin, О. A. Gromova, A. M. Lila

    Published 2022-10-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 417
    ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS

    ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS by M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva

    Published 2015-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 418
    Trends in the industry of clinical trials

    Trends in the industry of clinical trials by S. S. Milovanov, V. V. Popov, N. V. Teplova

    Published 2025-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 419
    PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING

    PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING by M. V. Protsenko, N. I. Koroleva

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 420
    Approaches to determining the cost of laboratory tests

    Approaches to determining the cost of laboratory tests by I. I. Khayrullin, V. V. Omelyanovskiy, R. V. Gostishchev, O. A. Sukhorukikh, S. A. Kovaleva, B. G. Gorodetsky

    Published 2024-08-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: